Biomedical Engineering Reference
In-Depth Information
85. Fraser SP, Diss JK, Chioni AM, Mycielska ME, Pan H, Yamaci RF, Pani F, Siwy Z,
Krasowska M, Grzywna Z, Brackenbury WJ, Theodorou D, Koyut
urk M, Kaya H, Battaloglu
E, De Bella MT, Slade MJ, Tolhurst R, Palmieri C, Jiang J, Latchman DS, Coombes RC,
Djamgoz MB (2005) Voltage-gated sodium channel expression and potentiation of human
breast cancer metastasis. Clin Cancer Res 11:5381-5389
86. Gillet L, Roger S, Besson P, Lecaille F, Gore J, Bougnoux P, Lalmanach G, Le Guennec JY
(2009) Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent inva-
siveness and colony growth of human cancer cells. J Biol Chem 284:8680-8691
87. Grimes JA, Fraser SP, Stephens GJ, Downing JE, Laniado ME, Foster CS, Abel PD, Djamgoz
MB (1995) Differential expression of voltage-activated Na
+
currents in two prostatic tumour
cell lines: contribution to invasiveness in vitro. FEBS Lett 369:290-294
88. Mycielska ME, Fraser SP, Szatkowski M, Djamgoz MB (2003) Contribution of functional
voltage-gated Na
+
channel expression to cell behaviors involved in the metastatic cascade in
rat prostate cancer: II. Secretory membrane activity. J Cell Physiol 195:461-469
89. Onganer PU, Seckl MJ, Djamgoz MB (2005) Neuronal characteristics of small-cell lung
cancer. Br J Cancer 93:1197-1201
90. Roger S, Rollin J, Barascu A, Besson P, Raynal PI, Iochmann S, Lei M, Bougnoux P, Gruel Y,
Le Guennec JY (2007) Voltage-gated sodium channels potentiate the invasive capacities of
human non-small-cell lung cancer cell lines. Int J Biochem Cell Biol 39:774-786
91. Sander JW (2003) The epidemiology of epilepsy revisited. Curr Opin Neurol 16:165-170
92. McCormick DA, Contreras D (2001) On the cellular and network bases of epileptic seizures.
Annu Rev Physiol 63:815-846
93. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med
342:314-319
94. Dodson WE (2004) Definitions and classification of epilepsy. In: Shorvon S, Perucca E, Fish
D, Dodson E (eds) The treatment of epilepsy. Blackwell Publishing, Oxford
95. Rogawski MA, Loscher W (2004) The neurobiology of antiepileptic drugs. Nat Rev Neurosci
5:553-564
96. Hille B (2001) Ionic channels of excitable membranes. Sinauer Associates Inc., Sunderland
97. Leppik IE (2004) Zonisamide: chemistry, mechanism of action, and pharmacokinetics.
Seizure 13:S5-S9
98. Loscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for
the treatment of epilepsy. CNS Drugs 16:669-694
99. Stefani A, Spadoni F, Siniscalchi A, Bernardi G (1996) Lamotrigine inhibits Ca
2+
currents in
cortical neurons: functional implications. Eur J Pharmacol 307:113-116
100. Zona C, Tancredi V, Longone P, D'Arcangelo G, D'Antuono M, Manfredi M, Avoli M
(2002) Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine.
Epilepsia 43:685-690
101. Shank RP, Maryanoff BE (2008) Molecular pharmacodynamics, clinical therapeutics, and
pharmacokinetics of topiramate. CNS Neurosci Ther 14:120-142
102. Gryder DS, Rogawski MA (2003) Selective antagonism of GluR5 kainate-receptor-mediated
synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci 23:7069-7074
103. Qian J, Noebels JL (2003) Topiramate alters excitatory synaptic transmission in mouse
hippocampus. Epilepsy Res 55:225-233
104. Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G (2008) Riluzole in the
treatment of mood and anxiety disorders. CNS Drugs 22:761-786
105. Curia G, Biagini G, Perucca E, Avoli M (2009) Lacosamide: a new approach to target
voltage-gated sodium currents in epileptic disorders. CNS Drugs 23:555-568
106. Errington AC, Stohr T, Heers C, Lees G (2008) The investigational anticonvulsant
lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol
Pharmacol 73:157-169
107. Errington AC, Coyne L, Stohr T, Selve N, Lees G (2006) Seeking a mechanism of action for
the novel anticonvulsant lacosamide. Neuropharmacology 50:1016-1029
€
